# 18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis

> **NCT06048601** · NA · UNKNOWN · sponsor: **Fondazione Toscana Gabriele Monasterio** · enrollment: 150 (estimated)

## Conditions studied

- Amyloid
- Amyloid Cardiomyopathy

## Interventions

- **DIAGNOSTIC_TEST:** 18F-florbetaben PET/CT

## Key facts

- **NCT ID:** NCT06048601
- **Lead sponsor:** Fondazione Toscana Gabriele Monasterio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-26
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06048601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06048601, "18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06048601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*